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GREEN V. ALPHARMA, INC.:
THE CAUSAL CONNECTION BETWEEN THE USE OF GROWTH
HORMONES IN CHICKEN FEED AND CANCER AND ITS IMPACT
ON THE AGRICULTURAL INDUSTRY
SUNNI R. HARRIS*
I. INTRODUCTION
Many people mistakenly believe that the equine sector provides the
largest stream of agricultural revenue into Kentucky. Surprisingly, the
state's true cash cow lies deep in the heart of the Bluegrass: industrial
chicken farms. While the putrid smell emitted from these chicken houses is
disquieting, even more alarming is poultry producers' willingness to feed
their chickens dangerous growth hormones that may cause cancer in nearby
residents. Farmers use growth hormones to make their chickens grow
larger than they would naturally; however, these growth hormones contain
arsenic, a compound that is not dangerous to chickens but can be fatal when
ingested by humans.' Arsenic can be ingested by humans as a result of
farmers using contaminated chicken litter to fertilize their crops.2 This
contaminated fertilizer seeps into the ground drinking water and pollutes
the air, thereby increasing humans exposure to arsenic.3 Human digestion
of arsenic can cause a host of different illnesses.4 While many of these
illnesses are serious, perhaps the most deadly is cancer. In Green v.
Alpharma, Inc. the court held there was a genuine issue of material fact as
to whether poultry producers were liable for cancer occurring in persons
living near poultry farms. 5
Section II of this Comment provides the historical and legal
background concerning the use of organic arsenic in chicken feed and the
use of contaminated chicken litter as fertilizer. Section III details the
background and procedural history of Green v. Alpharma, Inc. Section IV
discusses the Arkansas Supreme Court's analysis of the Plaintiff's prima
facie case which shows a causal connection between the use of arsenic in
* Staff Member, KENTUCKY JOURNAL OF EQUINE, AGRICULTURE, AND NATURAL
RESOURCES LAW 2009-2010. B.A. 2007, Vanderbilt University; J.D. expected May 2011, University of
Kentucky College of Law.
1 Crystal Whitney, Note, The Harmful Effects of Arsenic-Based Feed Additives in Poultry
Production, 13 DRAKE J. AGRiC. L. 583, 585-86 (2008).2 Id. at 595.31id.
4 1d. at 586.
5 Green v. Alpharma, Inc., 284 S.W.3d 29,43 (Ark. 2008).
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chicken feed and cancer. Section V delineates the implications of this
decision on poultry producing states, like Kentucky.
II. HISTORICAL AND LEGAL BACKGROUND
This section first examines the dangers in feeding arsenic growth
additives to chickens, the understanding of which is essential to the court's
analysis of the causal connection between the use of growth hormones in
chicken feed and cancer. Next, the significance of the poultry sector in
Kentucky is described. Finally, to adequately address the implications of
Green v. Alpharma, Inc., this section points out the lack of federal and state
regulation on the use of contaminated chicken litter.
A. The danger in feeding arsenic-containing growth additives to chickens
When fed to chickens, arsenic-containing growth additives can be
harmful to humans.6 Arsenic comes in two forms: organic and inorganic.7
Both types are effective at promoting growth, killing parasites, and
increasing pigmentation when fed to chickens as a feed additive.' As
testimony to arsenic's ability to promote growth in chickens, "it now takes
producers half the time that it took in 1957 to raise the chickens to market
weight."9 However, because of its harmful effects on humans, inorganic
arsenic is banned from being fed to chickens; consequently, poultry
producers feed their chickens organic arsenic to make them grow bigger
than they would naturally.'°
While organic arsenic in its original form poses no threat to humans
or chickens and is allowed for use in feed, problems arise when chickens
convert organic arsenic into inorganic arsenic through the digestive
process." Thus, "[d]espite the ban on the use of inorganic arsenic in
poultry production," humans are still exposed to the dangers of inorganic
arsenic when the chicken litter is used as fertilizer.' 2 This disposal method
increases human exposure to arsenic not only through air emissions, but
also through contact with contaminated soil, drinking water, and food
crops. 13
6 Whitney, supra note 1, at 586.




12 Whitney, supra note 1, at 588.
3 Id. at 595.
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Inorganic arsenic can affect human health in numerous ways. For
instance,
[i]norganic arsenic can irritate a person's stomach and
intestines, decrease blood cell production, cause fatigue
and abnormal heart rhythm, damage blood-vessels, impair
nerve function, and cause skin problems such as darkening,
corns, and warts. Inorganic arsenic has been identified as a
human carcinogen by the Department of Health and Human
Services and increases the risk of numerous types of
cancer. 14
Furthermore, children are at a higher risk of arsenic exposure and effects
from exposure than adults "due to diet, behavior, and a lower efficiency at
converting inorganic arsenic to organic." 5 "Evidence indicates that long
term exposure to arsenic" lowers a child's IQ scores. 16
B. The use of growth hormones in chicken feed in Kentucky
While Green v. Alpharma, Inc. is an Arkansas Supreme Court
decision, poultry production greatly affects Kentucky and dozens of other
states. The USDA 2007 Census of Agriculture found that the poultry
industry is the largest agricultural sector in Kentucky and is ranked the
number one food commodity in cash receipts.' 7 In fact, the poultry sector
provides the largest stream of agricultural revenues into Kentucky, bringing
$978 million into the Commonwealth, 8 while the equine sector amasses
only $952 million in receipts.' 9
Kentucky's poultry sector is not only lucrative, but widespread.
Approximately 850 chicken farms with 2,800 chicken houses are located in
Kentucky, ranking the state seventh in the nation regarding broiler
production.20 The concern, however, is that 70% of Kentucky's poultry
producers feed their chickens arsenic-based additives. 2' As explained
previously, the danger arises when this organic arsenic becomes inorganic
in a chicken's digestive system, and the resulting litter is either used on the
poultry producers' farms as fertilizer for their crops or sold to nearby grain
14 Id. at 586.
15 Id.
16 Id





21 See Whitney, supra note 1, at 585.
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22farmers at a cheaper price than petroleum-based fertilizers. As of now
there has been no Kentucky case where a party has alleged that a poultry
producer was the cause of his or her cancer. Nevertheless, given
Kentucky's large poultry production industry, it is only a matter of time
until the implications of Green v. Alpharma, Inc. reach Kentucky.
C. Neither the FDA nor Kentucky state law regulates the use of
contaminated chicken litter in crop fertilization.
While the FDA regulates the amount of organic arsenic being fed
to chickens,23 the FDA does not have a system in place to alert it when
poultry producers are not following these mandates. The FDA places the
burden of ensuring safe concentration levels of organic arsenic on the
manufacturers or distributors.24 Furthermore, while the inorganic arsenic is
banned from being fed to chickens,25 the FDA does not regulate the use of
chicken litter,26 which contains inorganic arsenic converted through the
chickens' digestive process, as fertilizer. Kentucky takes an equally passive
approach, claiming it has no authority to take enforcement action against
concentrated animal feeding operations.27
III. FACTS AND PROCEDURAL HISTORY OF GREEN v. ALPHARMA, INC.
The plaintiff, "Blu" Green, of Prairie Grove, Arkansas, was
diagnosed with chronic myelogenous leukemia in 1999.28 He lived and
attended school near several poultry farms.29  These farms fed their
chickens 3-Nitro 20, a growth additive, manufactured by Alpharma, one of
the defendants. 31 Importantly, 3-Nitro 20, like similar growth additives,
contains "roxarsone, an organic arsenical compound,"31 which breaks down
into the more toxic inorganic version.32 Poultry farmers that live near the
22 Keeton, supra note 17.
23 21 C.F.R. §558.530 (West, Westlaw through Feb. 19, 2010) (regulating the use of
roxarsone in chicken feed). Roxarsone is an organic arsenical compound. Green, 284 S.W.3d at 33.
24 Whitney, supra note 1, at 589.
25 Id. at 588.
26 See Melinda Wenner, Food for Chickens, Poison for Man, SCIENCELINE.COM, Sept. 20,
2006, http://www.scienceline.org/2006/09/20/env-wenner-arsenic/.
27 Krishtine de Leon, The Dark Side of Kentucky: Krishtine de Leon Reports on Tyson
Chicken Houses, ROLLING STONE, Mar. 9, 2007, available at
http://www.rollingstone.com/politics/story/13751913/the-dark-side-of kentuckykrishtine de leon re
portson tyson chickenhouses/2.
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Greens use the dried chicken litter to fertilize their fields.33 Blu complained
that the arsenic-laden chicken litter "polluted the air surrounding Prairie
Grove and infiltrated homes, schools, and places of business, thereby
causing" his leukemia.34 Blu contended that he was exposed to the chicken
litter through air, soil, and water. 35 Blu's complaint against Alpharma and
the poultry producers alleged: "(1) negligence, (2) negligence per se, (3)
intentional failure to warn, concealment, and/or misconduct, and (4) strict
liability/product liability.
36
In response to the complaint, the defendants filed separate motions
for summary judgment, arguing that there were no genuine issues of
material fact because the scientific community had not recognized a causal
connection between Blu's medical condition and the poultry litter.37 Blu
disagreed, claiming that there were remaining issues of fact relevant to the
defendants' liability.38  In support, he offered substantial deposition
testimony from local growers and spreaders.39
The circuit court granted the motion for summary judgment for the
poultry producers but denied Alpharma's motion.4 ° In granting summary
judgment in favor of the poultry producers, the circuit court rationalized
that Blu was unable to prove his exposure to "particular" defendant's
litter.41 In contrast, the circuit court denied summary judgment with respect
to Alpharma on the grounds that Alpharma was the supplier of roxarsone
for many years.42 The Arkansas Supreme Court reviewed whether the
circuit court erred in granting summary judgment in favor of the poultry
producers.43
IV. THE ARKANSAS SUPREME COURT'S ANALYSIS OF
GREEN v. ALPHARMA, INC.
Blu's principal argument was that the circuit court erred in finding
that he did not satisfy the "'frequency, regularity, and proximity"' test
gleaned from Chavers v. General Motors Corp., commonly referred to as
the Chavers test.44 Contrary to the circuit court's finding, Blu contended
33 id.
3 Green, 284 S.W.3d at 33.




40 Green, 284 S.W.3d at 34.
41 Id. at 35.
42 Id. The case went to trial and the jury found in favor of Alpharma. Id43 Id. at 35.
4Id. at 36 (quoting Chavers v. General Motors Corp., 79 S.W.3d 361 (Ark. 2002)).
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that Chavers v. General Motors Corp. supported a showing that Blu was
exposed to each particular poultry producer's litter. 5
In response to Blu's assertions, the Arkansas Supreme Court
analyzed the prongs of the Chavers test. Under this test, a plaintiff must
show that he was exposed (1) to a product made by the defendant, "(2) with
sufficient frequency and regularity, (3) in proximity to where he actually
worked," and (4) in such a way that it was probable that the exposure to the
defendant's products caused the plaintiff's injuries. 6
The Arkansas Supreme Court held that Blu met each prong of the
Chavers test.47 Blu proved the first prong, that he was exposed to the
arsenic- laced litter, through a substantial number of affidavits and
deposition testimony demonstrating a high concentration of arsenic in his
home that originated from poultry operations.48 He was also able to prove
the second prong, that he was exposed to chicken litter with sufficient
frequency and regularity, by submitting "evidence supporting the
proposition that the poultry producers had used the arsenic compound in the
chicken feed for a period of years." 49 Further, Blu provided testimony from
landowners and spreaders who admitted that they used chicken litter at a
school located one block from his home, satisfying the third prong of
proximate exposure.50 Lastly, because Blu was able to establish the first
three prongs, the causation requirement was also satisfied because it was
probable that the contaminated litter was the cause of his cancer. 51
Because Blu met the burden of the Chavers test, the Arkansas
Supreme Court held that "[w]hile the circuit court correctly [identified] the
factors of the Chavers test, [it] failed to [properly] apply" those factors to
the instant case.52 Therefore, the Arkansas Supreme Court "reverse[d] the
circuit court's grant of summary judgment in favor of the poultry producers
and remand[ed] the case" to the circuit court for a decision on the merits.
V. IMPLICATIONS
The decision in Green v. Alpharma has caused a significant shift in
judicial ideology.
45 id.
46 Green, 284 S.W.3d at 38 (emphasis omitted).
47 Id. at 42.
48 Id at 38-39.
49 Id. at 40.
50 Id. at41.
" Id. at42.
52 Green, 284 S.W.3d at 42.
" Id. at 43.
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A. Recognition of Causal Connection
Significantly, Green v. Alpharma, Inc. illustrates that courts are
beginning to acknowledge that use of chicken litter containing inorganic
arsenic can cause cancer in people living near areas where the fertilizer was
applied. Basically, this case has established the legitimacy and plausibility
of future claims from those injured by the spread of contaminated fertilizer
against manufacturers of arsenic grown additives and poultry producers.
As a result, this decision provides a means of recourse to those potentially
injured from exposure to arsenic.
Additionally, the decision in Green v. Alpharma, Inc. set forth the
correct application of the Chavers test in a toxic tort litigation case. While
the circuit court held that Blu fell short of meeting the burden, the Arkansas
Supreme Court made it clear that a prima facie showing can readily be
made with sufficient evidence. At a minimum, this allows future plaintiffs
to avoid summary judgment in favor of arsenic manufacturers and poultry
producers, thus giving plaintiffs a chance of arguing a case on the merits in
front of a jury. The plaintiffs' chances of success can be substantially
increased by pointing out the compelling scientific evidence discussed in
this Comment, especially if the injured party is a child. Moreover, further
guidance and support will be provided to future plaintiffs, if this case is
decided in favor of Blu on remand.
B. Increase in Toxic Tort Litigation
One can reasonably infer that, the landmark decision of Green v.
Alpharma, Inc. will open the floodgates to similar litigation across all
states, especially in high poultry producing states like Arkansas and
Kentucky. While states will certainly want to provide protection and
remedies to those affected by the potential negligence of poultry producers,
the fact remains that poultry production generates high revenue for many
states. Increased litigation surrounding this matter has the potential to
bankrupt small commercial farms and impact the state's revenue stream in
the aggregate. Even if none of Kentucky's 850 small commercial chicken
farms are subject to tort liability, the litigation costs alone may result in
bankruptcies.
Thus, there is a simple solution to the avoidance of litigation -
regulation. Both federal and state legislatures should regulate the use of
chicken fertilizer that contains inorganic arsenic. The fact that chicken
litter contaminates both groundwater and the air should provide a sufficient
incentive for arsenic's use to be stringently monitored at all governmental
levels. Moreover, the lack of governmental oversight on the use of organic
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arsenic in chicken feed should serve as a further incentive to effectively
regulate in this area. This factor is particularly important considering the
scientific evidence of chickens' natural ability to convert organic arsenic
into inorganic and the possibility that every person living in the vicinity of
poultry producers can contract a myriad of serious illnesses, including
cancer.
This regulation could take many forms. For example, the federal
and state systems could adopt the European approach and ban the use of
organic or inorganic arsenic in growth additives.54 This option would target
the manufacturers of arsenic-based additives and not the poultry producers.
While this European approach would eliminate the possibility of humans
contracting cancer from contaminated fertilizer, it is unlikely that the U.S.
is ready to institute such a broad sweeping rule. Organic and inorganic
growth additives provide a real utility to farmers because they aid in the
growth of chickens. Consumers may not be ready to sacrifice these larger
chickens when the use of contaminated fertilizer can be regulated in other
less intrusive ways. Moreover, on remand, Alpharma was not held liable
for causing Blu's cancer presumably because it was not deemed culpable.
Thus, it is reasonable to assume that if regulations are enacted, they would
directly target poultry producers instead of the manufacturers of arsenic-
based additives.
If poultry producers are allowed to continue using arsenic-based
growth additives, the regulations must focus on the use of contaminated
chicken litter. The only effective regulation may be to ban the use of
contaminated litter as fertilizer. Given the FDA's inability to monitor how
much organic arsenic chickens digest,55 the use of contaminated litter will
likewise be difficult to monitor, due to lack of administrative personnel or
high monitoring costs. As a solution, the regulation should be
supplemented by providing tax incentives to farms that comply with the
guidelines. By regulating the use of fertilizer and placing the brunt of the
burden on poultry producers, the number of people potentially incurring
cancer from contact with inorganic arsenic will be greatly reduced.
VI. CONCLUSION
Poultry production represents a major part of Kentucky's revenue
stream. However, poultry producers are potentially causing cancer in those
people that reside nearby because they feed their chickens arsenic-based
growth additives and subsequently use the contaminated litter as fertilizer.
The success of Blu in Green v. Alpharma, Inc. suggests a likely increase in
Whitney, supra note 1, at 596.
" Id at 589.
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toxic-tort litigation against the poultry producers. The answer to
suppressing the potential increase in litigation lies in the cooperation of
federal and state authorities in effectively regulating the use of
contaminated litter as fertilizer.

